Invention Grant
- Patent Title: Stable formulations for parenteral injection of peptide drugs
-
Application No.: US14188464Application Date: 2014-02-24
-
Publication No.: US09302010B2Publication Date: 2016-04-05
- Inventor: Steven Prestrelski , John Kinzell
- Applicant: Xeris Pharmaceuticals, Inc.
- Applicant Address: US TX Austin
- Assignee: Xeris Pharmaceuticals, Inc.
- Current Assignee: Xeris Pharmaceuticals, Inc.
- Current Assignee Address: US TX Austin
- Agency: Norton Rose Fulbright US LLP
- Main IPC: A61K38/29
- IPC: A61K38/29 ; A61K38/22 ; A61K38/26 ; A61K38/28 ; A61K47/26 ; A61K9/00 ; A61K9/19 ; A61K47/02 ; A61K47/10 ; A61K47/12 ; A61K47/14 ; A61K47/18 ; A61K47/20 ; A61K47/22 ; A61K38/09 ; A61K38/16 ; A61K38/17 ; A61K38/18 ; A61K38/25 ; A61K38/30 ; A61K38/48
Abstract:
Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations.
Public/Granted literature
- US20140171362A1 STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS Public/Granted day:2014-06-19
Information query
IPC分类:
